The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic
about
Targeted Therapies in Adult B-Cell MalignanciesThe insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potentialAbnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients.Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1.Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.Type I insulin-like growth factor receptor signaling in hematological malignancies.Targeting the Bone Marrow Microenvironment.Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax.
P2860
Q26783195-7BE87777-2131-4B90-935E-EACF32138B32Q28075927-231A10CD-36AE-4EFA-AB6E-C29514F4BF48Q35998168-97798D66-1A2D-4547-844C-70E73E6DB908Q36546659-CDA70E28-5BFD-4434-8986-BCDD80E96299Q36782357-4042EB8A-0E4E-47F7-BCD1-59B65AD2DC6BQ37702186-40BB0E03-8ECA-4958-AAE3-5B50A1F5E90CQ38970585-342A97BB-EBAA-4EB5-B7B1-B1598A54BDDAQ46370948-3A358218-44C6-4164-9D64-B27A4B5D7FF1
P2860
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The IGF-1 receptor inhibitor p ...... loma activity of a BH3-mimetic
@en
type
label
The IGF-1 receptor inhibitor p ...... loma activity of a BH3-mimetic
@en
prefLabel
The IGF-1 receptor inhibitor p ...... loma activity of a BH3-mimetic
@en
P2093
P2860
P50
P356
P1433
P1476
The IGF-1 receptor inhibitor p ...... loma activity of a BH3-mimetic
@en
P2093
Els Van Valckenborgh
Helena Jernberg-Wiklund
Karel Fostier
Karin Vanderkerken
Liesbeth Bieghs
Magnus Axelson
Mette Nyegaard
Olle Larsson
Rik Schots
Susanne Lub
P2860
P304
11193-11208
P356
10.18632/ONCOTARGET.1933
P407
P577
2014-11-01T00:00:00Z